Results 61 to 70 of about 442,357 (177)

Highlights in genitourinary cancers [PDF]

, 2019
From June 1st till June 5th, Chicago was host for the 55th annual ASCO meeting. This report will highlight the most important studies concerning genitourinary cancers presented during the ...
Vermassen, Tijl, Rottey, Sylvie
core  

Targeting Bone Metastases in Metastatic Castration-Resistant Prostate Cancer

Clinical Medicine Insights: Oncology, 2016
Skeletal involvement in metastatic castrate-resistant prostate cancer (mCRPC) is common and results in significant morbidity and mortality. The interaction of prostate cancer with the bone microenvironment contributes to progression of cancer in the bone
Joelle El-Amm, Jeanny B. Aragon-Ching
doaj   +1 more source

Emerging therapeutic agents for genitourinary cancers

Journal of Hematology & Oncology, 2019
The treatment of genitourinary malignancies has dramatically evolved over recent years. Renal cell carcinoma, urothelial carcinoma of the bladder, and prostate adenocarcinoma are the most commonly encountered genitourinary malignancies and represent a ...
Kevin Zarrabi, Azzam Paroya, Shenhong Wu
doaj   +1 more source

Three cases of double cancer: genitourinary and lung cancers [PDF]

, 1993
Three patients who had genitourinary cancer combined with lung cancer are reported. One patient had pulmonary adenocarcinoma and bladder transitional cell carcinoma, one had small cell lung cancer and squamous cell carcinoma of the penis, and one had ...
今尾, 貞夫, 三方, 律治, 小松, 秀樹   +2 more
core  

Genitourinary cancers: molecular determinants for personalized therapies

, 2016
Recent insights and emerging strategies for individualized therapeutic approaches in patients with genitourinary (GU) cancers are based on patient's genomic and cancer's molecular profiles.
Montironi R., Massari F., Raspollini M. R., Mazzucchelli R., Scarpelli M., Cheng L., Gasparrini S., Galosi A. B., Lopez-Beltran A.   +8 more
core   +2 more sources

Inside the 2016 American Society of Clinical Oncology Genitourinary Cancers Symposium: Part 2 - Prostate and bladder cancer

, 2016
The American Society of Clinical Oncology Genitourinary Cancers Symposium, Moscone West Building, San Francisco, CA, USA, 7-9 January 2016 The American Society of Clinical Oncology (ASCO) Genitourinary Cancers Symposium, held in San Francisco (CA, USA ...
Montironi R., Massari F., Scarpelli M., Cheng L., Ciccarese C., Buti S., Iacovelli R., Bersanelli M., Lopez-Beltran A., Tortora G.   +9 more
core   +2 more sources

Bisphosphonate anticancer activity in prostate cancer and other genitourinary cancers.

, 2012
Item does not contain fulltextAnticancer therapies have traditionally been targeted directly against cancer cell growth. However, newer treatment strategies also target the microenvironment that supports metastatic cancer cell growth. Bisphosphonates are
Saad, F., Mulders, P.F.A.
core   +1 more source

Incidence, mortality, and risk factors of bladder, kidney, prostate and testicular cancers in China and comparisons with the United States, the United Kingdom, Japan, and the Republic of Korea: an up-to-date overview based on the Global Burden of Disease 2021

Experimental Hematology & Oncology
Background The burden of genitourinary cancers has significantly changed in China over the recent decades. This study aims to identify the epidemiological trends and disparities in four common genitourinary cancers, including bladder, kidney, prostate ...
Gaohaer Kadeerhan, Zhongji Jiang, Hong Guo, Xinzhi Ma, Jin Zhang, Wenmin Guo, Jiedong Jia, Yibo Gao, Dongwen Wang   +8 more
doaj   +1 more source

Metastatic Sites in Rare Genitourinary Malignancies and Primary Cancer Sites in Genitourinary Organ Metastases: A Secondary Analysis Using the Japanese Pathological Autopsy Registry Database

European Urology Open Science
Background: The epidemiology of metastases from rare genitourinary cancer and metastases to genitourinary organs from other primary neoplasms remains poorly understood. Objective: To investigate the epidemiology of rare genitourinary metastases from rare
Suguru Oka, Tomohiko Hara, Shinji Ito, Michikata Hayashida, Kazushige Sakaguchi, Shinji Urakami   +5 more
doaj   +1 more source

Circulating Tumor DNA in Genitourinary Cancers: Detection, Prognostics, and Therapeutic Implications. [PDF]

Cancers (Basel)
CtDNA is emerging as a non-invasive clinical detection method for several cancers, including genitourinary (GU) cancers such as prostate cancer, bladder cancer, and renal cell carcinoma (RCC).
Gerke MB, Jansen CS, Bilen MA.
europepmc   +2 more sources